tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
DSGN
Design Therapeutics
RESEARCH TOOLSreports

Design Therapeutics (DSGN) Financial Statements

Compare
98 Followers

Design Therapeutics Financial Overview

Design Therapeutics's market cap is currently $660.51M. The company's EPS TTM is $-0.27; its P/E ratio is -7.71; Design Therapeutics is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -622.00K$ -596.00K$ -537.00K$ -466.00K$ 0.00
Operating Income$ -79.47M$ -62.38M$ -78.19M$ -67.59M$ -35.83M
EBITDA$ -78.84M$ -48.99M$ -66.33M$ -62.84M$ -35.70M
Net Income$ -69.79M$ -49.59M$ -66.86M$ -63.31M$ -35.53M
Balance Sheet
Cash & Short-Term Investments$ 219.84M$ 245.48M$ 281.80M$ 330.39M$ 384.06M
Total Assets$ 226.20M$ 252.09M$ 289.64M$ 341.14M$ 390.56M
Total Debt$ 645.00K$ 2.33M$ 3.05M$ 3.69M$ 3.63M
Net Debt$ -16.21M$ -20.23M$ -18.15M$ -22.81M$ -294.94M
Total Liabilities$ 13.70M$ 10.00M$ 11.96M$ 13.83M$ 8.43M
Stockholders' Equity$ 212.50M$ 242.10M$ 277.69M$ 327.31M$ 382.13M
Cash Flow
Free Cash Flow$ -54.55M$ -43.45M$ -58.82M$ -52.23M$ -30.91M
Operating Cash Flow$ -54.36M$ -43.10M$ -58.56M$ -51.32M$ -29.38M
Investing Cash Flow$ 22.91M$ 43.95M$ 52.54M$ -220.99M$ -53.64M
Financing Cash Flow$ 25.74M$ 513.00K$ 724.00K$ 235.00K$ 379.21M
Currency in USD

Design Therapeutics Earnings and Revenue History

Income Statement >

Design Therapeutics Debt to Assets

Balance Sheet >

Design Therapeutics Cash Flow

Cash Flow >

Design Therapeutics Forecast EPS vs Actual EPS

Earnings >